Agios Pharmaceuticals (AGIO) Shares Repurchased (2021)
Agios Pharmaceuticals (AGIO) reported Shares Repurchased of $19.0 million for Q4 2021, down 92.51% quarter-over-quarter from $254.4 million in Q3 2021.
Agios Pharmaceuticals (AGIO) Shares Repurchased (2021) Analysis & Trends
Agios Pharmaceuticals has reported Shares Repurchased for 1 years, with the latest figure at $19.0 million in Q4 2021.
- For the quarter ending Q4 2021, Shares Repurchased changed N/A year-over-year to $19.0 million; the trailing twelve-month figure through Dec 2022 stood at $273.4 million (changed 0.0% YoY), and the FY2021 full-year result was $802.5 million, changed N/A from the prior year.
- Shares Repurchased for Q4 2021 stood at $19.0 million, down from $254.4 million in the prior quarter.
- The five-year high for Shares Repurchased was $254.4 million in Q3 2021, with the low at $19.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 839,896.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 336.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 19.05 Mn |
| Dec 31, 2021 | 19.05 Mn |
| Sep 30, 2021 | 254.39 Mn |
| Sep 30, 2021 | 254.39 Mn |